White label ELPA - ClinicalTrials.eu

Study on Rivaroxaban for Patients with Atrial Fibrillation and Coronary Artery Disease After Heart Procedure

Not recruiting

3 1 1 1
Investigated Diseases:
- Coronary artery disease
- Atrial fibrillation
Investigated Drugs:
- Rivaroxaban
Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Not recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:
Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

Not recruiting

3 1
Investigated Diseases:
- Chronic kidney disease
- Proteinuria
Investigated Drugs:
- Finerenone
+11
Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

Not recruiting

1 1 1
Investigated Diseases:
- Dermatitis atopic
Investigated Drugs:
- Img-007
Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Not recruiting

3 1 1 1
Investigated Diseases:
- Myelofibrosis
Investigated Drugs:
+5
Study on Testosterone Undecanoate Effects on Liver Fat in Obese Men with Low Testosterone and Type 2 Diabetes or Prediabetes

Not recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Testosterone Undecanoate
Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Not recruiting

3 1
Investigated Diseases:
- Alopecia areata
Investigated Drugs:
- Upadacitinib
+7
Study of Relatlimab, Nivolumab, and Drug Combination for Patients with Advanced Cancer

Not recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Study on Oral PHA-022121 for Preventing Angioedema Attacks in Patients with Hereditary Angioedema

Not recruiting

2 1
Investigated Diseases:
- Hereditary angioedema with C1 esterase inhibitor deficiency
- Hereditary angioedema
Investigated Drugs:
- (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
Study on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy

Not recruiting

4 1
Investigated Drugs:
- Litifilimab
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies